T2 Biosystems Announces Advances in Novel Hemostasis Direct Detection Program
Published: Apr 16, 2013
LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced advances in its hemostasis product development program for T2HemoStat™, which rapidly detects physical changes in a blood sample such as coagulation, fibrinolysis and platelet function, from small volumes of whole blood or plasma on a single, compact instrument.